Q32 Bio Inc. Quarterly Debt-to-equity in % from Q3 2018 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Q32 Bio Inc. quarterly Debt-to-equity history and growth rate from Q3 2018 to Q4 2024.
  • Q32 Bio Inc. Debt-to-equity for the quarter ending December 31, 2024 was 346 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 346 +389 Dec 31, 2024
Q3 2024 -485 -450 -1286% Sep 30, 2024
Q2 2024 -142 -42.6 -43% Jun 30, 2024
Q1 2024 -74.8 -182 -170% Mar 31, 2024
Q4 2023 -43 -76 -230% Dec 31, 2023
Q3 2023 -35 -55.8 -268% Sep 30, 2023
Q2 2023 -99.2 -118 -631% Jun 30, 2023
Q1 2023 107 +89.3 +500% Mar 31, 2023
Q4 2022 33 +15.1 +83.9% Dec 31, 2022
Q3 2022 20.9 +0.35 +1.71% Sep 30, 2022
Q2 2022 18.7 -5.85 -23.9% Jun 30, 2022
Q1 2022 17.9 -11.5 -39.1% Mar 31, 2022
Q4 2021 18 -14 -43.8% Dec 31, 2021
Q3 2021 20.5 -7.25 -26.1% Sep 30, 2021
Q2 2021 24.5 -0.74 -2.93% Jun 30, 2021
Q1 2021 29.3 +6.96 +31.1% Mar 31, 2021
Q4 2020 32 +8.77 +37.8% Dec 31, 2020
Q3 2020 27.8 +1.83 +7.06% Sep 30, 2020
Q2 2020 25.3 -1.6 -5.96% Jun 30, 2020
Q1 2020 22.4 -4.81 -17.7% Mar 31, 2020
Q4 2019 23.2 -11.2 -32.7% Dec 31, 2019
Q3 2019 25.9 -24.8 -48.9% Sep 30, 2019
Q2 2019 26.9 Jun 30, 2019
Q1 2019 27.2 Mar 31, 2019
Q4 2018 34.4 Dec 31, 2018
Q3 2018 50.8 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.